Nutex Health Inc
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
NUTX$194.16+7.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| · · Year ended December 31, | |||||||||
| | 2023 | 2022 | 2021 | ||||||
| Revenue: | | | | | | | | | |
| Hospital division | | $218,070,397 | | $198,508,245 | | $331,531,311 | |||
| Population health management division | | | 29,575,919 | | | 20,786,061 | | | - |
| Total revenue | | | 247,646,316 | | | 219,294,306 | | | 331,531,311 |
| | | | | | | | | | |
| Operating costs and expenses: | | | | | | | | ||
| Payroll | | | 108,377,938 | | | 111,785,110 | | | 93,523,438 |
| Contract services | | | 42,349,982 | | | 35,913,441 | | | 17,050,957 |
| Medical supplies | | | 14,151,140 | | | 12,118,893 | | | 12,514,367 |
| Depreciation and amortization | | 17,591,572 | | 13,131,374 | | 7,662,464 | |||
| Other | | | 30,401,513 | | | 30,923,750 | | | 21,499,127 |
| Total operating costs and expenses | | | 212,872,145 | | | 203,872,568 | | | 152,250,353 |
| | | | | | | | | | |
| Gross profit | | | 34,774,171 | | | 15,421,738 | | | 179,280,958 |
| | | | | | | | | | |
| Corporate and other costs: | | | | | | | | | |
| Facilities closing costs | | | 217,266 | | | - | | | - |
| Acquisition costs | | | 43,464 | | | 3,885,666 | | | 3,553,716 |
| Stock-based compensation | | | 2,835,971 | | | 189,581 | | | - |
| Impairment of assets | | | 29,082,203 | | | - | | | - |
| Impairment of goodwill | | | 1,139,297 | | | 398,135,038 | | | - |
| General and administrative expenses | | | 33,229,718 | | | 19,810,607 | | | 5,462,344 |
| Total corporate and other costs | | | 66,547,919 | | | 422,020,892 | | | 9,016,060 |
| | | | | | | | | | |
| Operating income (loss) | | (31,773,748) | | | (406,599,154) | | | 170,264,898 | |
| | | | | | | | | | |
| Interest expense, net | | | 16,317,869 | | | 12,490,260 | | | 6,196,026 |
| Other expense (income) | | 399,182 | | 559,299 | | (5,422,144) | |||
| Income (loss) before taxes | | | (48,490,799) | | | (419,648,713) | | | 169,491,016 |
| | | | | | | | | | |
| Income tax expense (benefit) | | | (5,067,084) | | | 13,090,905 | | | 965,731 |
| | | | | | | | | | |
| Net income (loss) | | | (43,423,715) | | | (432,739,618) | | | 168,525,285 |
| | | | | | | | | | |
| Less: net income (loss) attributable to noncontrolling interests | | | 2,362,899 | | | (7,959,172) | | | 35,931,957 |
| | | | | | | | | | |
| Net income (loss) attributable to Nutex Health Inc. | | $(45,786,614) | | $(424,780,446) | | $132,593,328 | |||
| | | | | | | | | | |
| Earnings (loss) per common share | | | | | | | | | |
| Basic | | $(0.07) | | $(0.67) | | $0.22 | |||
| Diluted | | $(0.07) | | $(0.67) | | $0.22 | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.